Atlas Trials

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Clinical trial NCT04248452 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04248452
Sponsor
ECOG-ACRIN Cancer Research Group
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Clinical Stage IV Esophageal Adenocarcinoma AJCC v8Clinical Stage IV Gastric Cancer AJCC v8Clinical Stage IVA Esophageal Adenocarcinoma AJCC v8Clinical Stage IVA Gastric Cancer AJCC v8Clinical Stage IVB Esophageal Adenocarcinoma AJCC v8Clinical Stage IVB Gastric Cancer AJCC v8Metastatic Esophageal AdenocarcinomaMetastatic Gastric AdenocarcinomaOligometastatic Esophageal AdenocarcinomaOligometastatic Gastric AdenocarcinomaPathologic Stage IV Esophageal Adenocarcinoma AJCC v8Pathologic Stage IV Gastric Cancer AJCC v8
Start date
2020-05-26
Primary completion
2028-03-31
Enrollment
314

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.